Issue 1-2/2012

  • BASF Plant Science quits Europe for the US

    Topics in this issue:

    • Roche makes hostile bid for US sequencing specialist Illumina
    • BioInvent International teams up with Servier in oncology
    • French government boosts seed funding for biotech firms
    • Euro BioFairs Compass 1/12: Guide to life sciences events
    • Spanish Okairos delivers novel vaccine platform technology
    • BIA Separations to cooperate with Japanese industrial giant
    • Researchers model human body to predict drug response

Volume 2014

Volume 2013

Volume 2012

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/magazine/ebsin/2012/1-2/pos/1.html?sort=desc&cHash=f5f2e5fdbfbf799a701ac9c5e77ce04b

Kurszettel

Alle Kurse

TOP

  • CHRONTECH PHARMA (S)0.08 SEK14.29%
  • THERAMETRICS (CH)0.09 CHF12.50%
  • AB SCIENCE (F)11.21 EUR9.37%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • SERODUS (N)2.81 NOK-10.79%

TOP

  • WILEX (D)2.80 EUR229.4%
  • ADDEX (CH)4.01 CHF67.1%
  • 4SC (D)1.42 EUR46.4%

FLOP

  • HYBRIGENICS (F)1.74 EUR-28.7%
  • PROSENSA (NL)9.65 USD-24.0%
  • VITA 34 (D)4.21 EUR-19.8%

TOP

  • SANTHERA (CH)65.50 CHF3095.1%
  • GW PHARMACEUTICALS (UK)412.50 GBP630.1%
  • PAION (D)2.74 EUR302.9%

FLOP

  • EVOCUTIS (UK)0.21 GBP-92.2%
  • CYTOS (CH)0.28 CHF-91.8%
  • THROMBOGENICS (B)9.45 EUR-69.6%

No liability assumed, Date: 29.07.2014